⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALKS News
Alkermes Inc. plc
Form 8-K
sec.gov
ALKS
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
globenewswire.com
ALKS
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research
businesswire.com
ALKS
Alkermes to Participate in the Goldman Sachs 47 th Annual Global Healthcare Conference
businesswire.com
ALKS
UserTesting Announces 2026 Illumi Award Winners
businesswire.com
MSFT
AAL
CARM
AFRM
ALKS
Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
businesswire.com
ALKS
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
Form 8-K
sec.gov
ALKS
Prevent Blindness to Host the 2026 ASPECT Patient Engagement Summit and Eyes on Capitol Hill Legislative Advocacy Day in Washington, D.C.
prnewswire.com
GILD
REGN
AMGN
JNJ
MRK
ALKS
APLS
EYPT
OCUL
VRTX
Form 8-K
sec.gov
ALKS